Oral vs Intravesical Analgesia for Office Bladder Botox Injections

Inclusion Criteria: * Non-pregnant, adult females 18 years of age or older * Diagnosis of idiopathic overactive bladder * Planning office-based bladder injection of onabotulinumtoxinA * Willing and able to complete all study related items and interviews * Grossly neurologically normal on exam Exclusion Criteria: * Known neurologic diseases (multiple sclerosis, Parkinson Disease, CVA within 6 months, myasthenia gravis, Charcot-Marie-Tooth disease, peripheral neuropathy, and complete spinal cord injury) believed to affect urinary function * Planned injection of \>100 units of onabotulinumtoxinA * OnabotulinumtoxinA given for another indication within the previous 3 months (if cumulative dose would total \>400 units) * Any intradetrusor onabotulinumtoxinA injections in the previous 12 months * Serum creatinine level greater than twice the upper limit of normal within the year prior to enrollment * Allergy to lidocaine * Allergy to onabotulinumtoxinA * Allergy to phenazopyridine * Untreated urinary tract infection (UTI) * Currently pregnant or lactating. * Known urinary retention (post-void residual \>200mL) and inability to perform intermittent self-catheterization * Uninvestigated hematuria (gross or microscopic) * Current or prior bladder malignancy * Previous bladder augmentation or surgically altered detrusor muscle * Prior pelvic radiation * Primary language other than English or Spanish